China perseveres with mRNA COVID shot development amid Omicr

By Roxanne Liu and David Stanway BEIJING/SHANGHAI (Reuters) - China has spent over a year developing Pfizer-type COVID-19 vaccines that may even help ...

Related Keywords

Beijing , China , Australia , Shanghai , Hong Kong , Chinese , David Stanway , Zhang Jialin , Christopher Cushing , Roxanne Liu , Miyoung Kim , Zhao Bing , Jaya Dantas , National Health Commission , Michael Hirson At Eurasia Group , Walvax Biotechnology Co Ltd , Reuters , Suzhou Abogen Biosciences Co Ltd , Curtis School Of Population Health , Pfizer Inc , Moderna Inc , Academy Of Military Medical Sciences , Curtis School , Population Health , Michael Hirson , Military Medical Sciences , China Renaissance Securities , Bryan Dent Wood , ,